Wellington Management Group LLP Celldex Therapeutics, Inc. Transaction History
Wellington Management Group LLP
- $545 Billion
- Q3 2025
A detailed history of Wellington Management Group LLP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 5,800,003 shares of CLDX stock, worth $148 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,800,003
Previous 5,232,326
10.85%
Holding current value
$148 Million
Previous $106 Million
40.92%
% of portfolio
0.03%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding CLDX
# of Institutions
205Shares Held
66.8MCall Options Held
222KPut Options Held
234K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$156 Million13.34% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.95MShares$101 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.89MShares$99.5 Million0.2% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.56MShares$90.9 Million1.97% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.2B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...